Literature DB >> 26375622

A review of ethylphenidate in deaths in east and west Scotland.

Claire Parks1, Denise McKeown2, Hazel J Torrance3.   

Abstract

Ethylphenidate is a psychostimulant and analogue of methylphenidate. Interestingly it is also produced as a metabolite from the co-ingestion of methylphenidate and alcohol (ethanol). In the UK, between April and June 2015, ethylphenidate and 6 other methylphenidate based novel psychoactive substances (NPS) were subjected to a temporary class drug order under the Misuse of Drugs Act 1971. Ethylphenidate is being abused by both novel and habitual drug users, more prominently in the East of Scotland. What is unknown in the literature is the contribution of ethylphenidate in deaths. A search was conducted for an 18 month period (July 2013 to December 2014) to identify cases where ethylphenidate was detected during post-mortem toxicological analysis. Nineteen cases were identified and these cases were examined with regards to case circumstances, pathology findings, toxicology results and adverse effects. The individuals ranged in age from 20 to 54 (median 37) and the majority were male (n=14) and from the East of Scotland (n=16), more specifically Edinburgh and surrounding area. Current or previous heroin abuse was a common theme in these cases (n=16) and injection was a common route of administration of "legal highs" or "burst". The concentration of ethylphenidate in the cases ranged from 0.008 mg/L to over 2 mg/L in post-mortem femoral blood (median 0.25 mg/L, average 0.39 mg/L). Other drugs commonly detected were benzodiazepines (n=15), followed by opiates (n=11, 4 of which were positive for 6-monoacetylmorphine) and then methadone (n=8). All 19 cases received a full post-mortem examination and there were 10 cases where drug toxicity was the sole or potentially contributory factor to the cause of death. Ethylphenidate was specifically mentioned in the cause of death for 5 cases, chronic intravenous (IV) drug use was named as part of the cause of death for 2 cases and in 6 cases there was evidence of complications and infections through IV drug use. As far as it is known to the authors, this is the first review of post-mortem cases involving the use of ethylphenidate in East and West Scotland. This study can be used as a guide for toxicologists and pathologists when interpreting cases which are positive for ethylphenidate.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ethylphenidate; Fatalities; Legal highs; Post-mortem

Mesh:

Substances:

Year:  2015        PMID: 26375622     DOI: 10.1016/j.forsciint.2015.08.008

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  5 in total

1.  Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; John D Power; Geraldine Dowling; Brendan Twamley; John O'Brien; Gary Hessman; Brian Murphy; Donna Walther; John S Partilla; Michael H Baumann; Simon D Brandt
Journal:  Drug Test Anal       Date:  2017-03-07       Impact factor: 3.345

2.  New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh.

Authors:  Janice Pettie; Allan Burt; Duleeka W Knipe; Hazel Torrance; Margaret Dow; Karen Osinski; Robert Greig; Diletta Sabatini; Kate Easterford; James Dear; Michael Eddleston
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

3.  Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice.

Authors:  Meridith T Robins; Arryn T Blaine; Jiwon E Ha; Amy L Brewster; Richard M van Rijn
Journal:  Front Neurosci       Date:  2019-02-19       Impact factor: 4.677

4.  Characteristics of NPS use in patients admitted to acute psychiatric services in Southeast Scotland: a retrospective cross-sectional analysis following public health interventions.

Authors:  Kyle H Bennett; Helen M Hare; Robert M Waller; Helen L Alderson; Stephen Lawrie
Journal:  BMJ Open       Date:  2017-12-03       Impact factor: 2.692

Review 5.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.